Literature DB >> 19531667

Plate-based diversity selection based on empirical HTS data to enhance the number of hits and their chemical diversity.

Sai Chetan K Sukuru1, Jeremy L Jenkins, Rohan E J Beckwith, Josef Scheiber, Andreas Bender, Dmitri Mikhailov, John W Davies, Meir Glick.   

Abstract

Typically, screening collections of pharmaceutical companies contain more than a million compounds today. However, for certain high-throughput screening (HTS) campaigns, constraints posed by the assay throughput and/or the reagent costs make it impractical to screen the entire deck. Therefore, it is desirable to effectively screen subsets of the collection based on a hypothesis or a diversity selection. How to select compound subsets is a subject of ongoing debate. The authors present an approach based on extended connectivity fingerprints to carry out diversity selection on a per plate basis (instead of a per compound basis). HTS data from 35 Novartis screens spanning 5 target classes were investigated to assess the performance of this approach. The analysis shows that selecting a fingerprint-diverse subset of 250K compounds, representing 20% of the screening deck, would have achieved significantly higher hit rates for 86% of the screens. This measure also outperforms the Murcko scaffold-based plate selection described previously, where only 49% of the screens showed similar improvements. Strikingly, the 2-fold improvement in average hit rates observed for 3 of 5 target classes in the data set indicates a target bias of the plate (and thus compound) selection method. Even though the diverse subset selection lacks any target hypothesis, its application shows significantly better results for some targets-namely, G-protein-coupled receptors, proteases, and protein-protein interactions-but not for kinase and pathway screens. The synthetic origin of the compounds in the diverse subset appears to influence the screening hit rates. Natural products were the most diverse compound class, with significantly higher hit rates compared to the compounds from the traditional synthetic and combinatorial libraries. These results offer empirical guidelines for plate-based diversity selection to enhance hit rates, based on target class and the library type being screened.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19531667     DOI: 10.1177/1087057109335678

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  17 in total

1.  Development and Testing of Druglike Screening Libraries.

Authors:  Junmei Wang; Yubin Ge; Xiang-Qun Xie
Journal:  J Chem Inf Model       Date:  2019-01-03       Impact factor: 4.956

Review 2.  No time to lose--high throughput screening to assess nanomaterial safety.

Authors:  R Damoiseaux; S George; M Li; S Pokhrel; Z Ji; B France; T Xia; E Suarez; R Rallo; L Mädler; Y Cohen; E M V Hoek; A Nel
Journal:  Nanoscale       Date:  2011-02-07       Impact factor: 7.790

Review 3.  The re-emergence of natural products for drug discovery in the genomics era.

Authors:  Alan L Harvey; RuAngelie Edrada-Ebel; Ronald J Quinn
Journal:  Nat Rev Drug Discov       Date:  2015-01-23       Impact factor: 84.694

4.  The 160K Natural Organism Library, a unique resource for natural products research.

Authors:  Siew Bee Ng; Yoganathan Kanagasundaram; Hao Fan; Prakash Arumugam; Birgit Eisenhaber; Frank Eisenhaber
Journal:  Nat Biotechnol       Date:  2018-07-06       Impact factor: 54.908

5.  Plate-based diversity subset screening: an efficient paradigm for high throughput screening of a large screening file.

Authors:  Andrew S Bell; Joseph Bradley; Jeremy R Everett; Michelle Knight; Jens Loesel; John Mathias; David McLoughlin; James Mills; Robert E Sharp; Christine Williams; Terence P Wood
Journal:  Mol Divers       Date:  2013-04-05       Impact factor: 2.943

6.  Combined Scaffold Evaluation and Systems-Level Transcriptome-Based Analysis for Accelerated Lead Optimization Reveals Ribosomal Targeting Spirooxindole Cyclopropanes.

Authors:  Kevin X Rodriguez; Erin N Howe; Emily P Bacher; Miranda Burnette; Jennifer L Meloche; Jayda Meisel; Patricia Schnepp; Xuejuan Tan; Mayland Chang; Jeremiah Zartman; Siyuan Zhang; Brandon L Ashfeld
Journal:  ChemMedChem       Date:  2019-07-01       Impact factor: 3.466

7.  Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents.

Authors:  Stephen M Massa; Tao Yang; Youmei Xie; Jian Shi; Mehmet Bilgen; Jeffrey N Joyce; Dean Nehama; Jayakumar Rajadas; Frank M Longo
Journal:  J Clin Invest       Date:  2010-04-19       Impact factor: 14.808

Review 8.  Natural product-informed exploration of chemical space to enable bioactive molecular discovery.

Authors:  Adam Nelson; George Karageorgis
Journal:  RSC Med Chem       Date:  2020-12-16

9.  Targeting SUMOylation dependency in human cancer stem cells through a unique SAE2 motif revealed by chemical genomics.

Authors:  Yannick D Benoit; Ryan R Mitchell; Wenliang Wang; Luca Orlando; Allison L Boyd; Borko Tanasijevic; Lili Aslostovar; Zoya Shapovalova; Meaghan Doyle; Christopher J Bergin; Kinga Vojnits; Fanny L Casado; Justin Di Lu; Deanna P Porras; Juan Luis García-Rodriguez; Jennifer Russell; Aïcha Zouggar; Angelique N Masibag; Cody Caba; Kalinka Koteva; Lakshmana K Kinthada; Jagdish Suresh Patel; Sara N Andres; Jakob Magolan; Tony J Collins; Gerard D Wright; Mickie Bhatia
Journal:  Cell Chem Biol       Date:  2021-05-11       Impact factor: 9.039

10.  Mining collections of compounds with Screening Assistant 2.

Authors:  Vincent Le Guilloux; Alban Arrault; Lionel Colliandre; Stéphane Bourg; Philippe Vayer; Luc Morin-Allory
Journal:  J Cheminform       Date:  2012-08-31       Impact factor: 5.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.